Knowledge, Representations, Attitudes, and Behaviors of Women Faced With Taking Medications While Breastfeeding

Spiesser-Robelet, Laurence; Brunie, Vanida; Andrade, Vincent De; Gagnayre, Rémi

doi:10.1177/0890334416679383

Cited by 28 publications

(26 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our results converged with scientific literature data on BW knowledge and representations about medication. According to many participants, representations were focused on milk passage and adverse effects of medications on children, which brought anxiety or culpability (Spiesser-Robelet et al, 2017). These elements contribute to understanding mothers' distrust toward medication reported by participants in our study, which is also described in previous studies (Colaceci et al, 2016;Spiesser-Robelet et al, 2017).…”

Section: Discussionsupporting

confidence: 65%

Understanding Breastfeeding Women’s Behaviors Toward Medication: Healthcare Professionals’ Viewpoint

2018

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 65%

Understanding Breastfeeding Women’s Behaviors Toward Medication: Healthcare Professionals’ Viewpoint

2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…Due to unwarranted concerns, women might not try to get pregnant or pregnancies may be terminated unnecessarily, whereas fetal development in other pregnancies may be put at risk because of exposure to medication with unknown teratogenic effects [ 11 , 19 ]. In addition, neonates may not benefit from breastfeeding due to non-initiation or cessation when the mother needs medication [ 20 , 21 ].…”

Section: Introductionmentioning

confidence: 99%

Aim and Design of pREGnant, the Dutch Pregnancy Drug Register

et al. 2018

View full text Add to dashboard Cite

Information on the safety of medication use during pregnancy and breastfeeding is scarce, yet use of medication among pregnant and breastfeeding women is widespread. The pREGnant, the Dutch Pregnancy Drug Register, was set up to obtain insight into medication use among pregnant and breastfeeding women and potential effects on maternal and fetal/infant health. The systematically documented, good quality data on medication use during pregnancy and lactation in pREGnant will be used in signal detection, epidemiologic studies and counseling of healthcare providers and patients. The register has a prospective cohort design. The population is derived from pregnant women throughout the Netherlands. Data collection started in April 2014 and enrollment of women is continuous and is characterized by a relative high proportion of women born in the Netherlands with a high education compared with the general Dutch pregnant population. Data on current pregnancy, obstetric history, maternal lifestyle, health and medication use, delivery, and infant health are collected through web-based questionnaires completed by the participating women (three times during pregnancy and three times during the infant’s first year of life). If permission is given, the self-reported data can be complemented with information retrieved from Perined, the perinatal registry of the Netherlands, and from obstetric and medical records, and/or pharmacy records. Here, we provide detailed information on the design of the pREGnant, the Dutch Pregnancy Drug Register, as well as descriptive information on characteristics of the participants so far. Currently, steps are being taken to implement the register on a large scale in the Netherlands.

show abstract

“…The most commonly prescribed drug classes are oral analgesics, antibiotics, and vitamins during the postpartum period 44. Mothers and providers may be uncertain about medication use due to concerns about the adverse impact on the newborn’s health; decisions not to initiate or stop treatment may pose risks to the mother’s health 45…”

Section: Prenatal and Newborn Periodmentioning

confidence: 99%

<p>Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges</p>

Haga

2019

PGPM

View full text Add to dashboard Cite

For the past several years, the implementation of pharmacogenetic (PGx) testing has become widespread in several centers and clinical practice settings. PGx testing may be ordered at the point-of-care when treatment is needed or in advance of treatment for future use. The potential benefits of PGx testing are not limited to adult patients, as children are increasingly using medications more often and at earlier ages. This review provides some background on the use of PGx testing in children as well as mothers (prenatally and post-natally) and discusses the challenges, benefits, and the ethical, legal, and social implications of providing PGx testing to children.

show abstract

Knowledge, Representations, Attitudes, and Behaviors of Women Faced With Taking Medications While Breastfeeding

Abstract: The results of this review confirm the need for a qualitative study to explore the knowledge, representations, and attitudes of breastfeeding women faced with taking medications, so that we can understand their connection with observed behaviors and take appropriate educational action.

Cited by 28 publications

References 42 publications

Understanding Breastfeeding Women’s Behaviors Toward Medication: Healthcare Professionals’ Viewpoint

Understanding Breastfeeding Women’s Behaviors Toward Medication: Healthcare Professionals’ Viewpoint

Aim and Design of pREGnant, the Dutch Pregnancy Drug Register

<p>Pharmacogenomic Testing In Pediatrics: Navigating The Ethical, Social, And Legal Challenges</p>

Contact Info

Product

Resources

About